infarction (STEMI) myocardial infarction (NSTEMI) STEMI STEMI represent the most lethal form acute coronary syndrome ,in which a completely occlusive thrombus typically results in total cessation of coronary blood flow , manifested electrically as elevation of the ST segment of the ECG. Pathogenesis Acute coronary syndrome almost occurs in patient who have atherosclerosis. The initial event is a sudden change in the structure of an atheromatous plaque, i.e. disruption as intraplaque hemorrhage, ulceration, or rupture. This results in thrombus formation. Frequently within minutes, the thrombus evolves to completely occlude the lumen of the coronary artery. Clinical features Prolonged cardiac pain Nausea and vomiting Breathlessness Syncope Hypotension , oliguria Raised jugular venous pressure Third heart sound Complications Early complication:- Disturbance of rate, rhythm, and conduction Left ventricular failure Right ventricular failure Cerebrovascular accident Pricarditis Late complications:- Heart failure Ventricular aneurysm Thromboembolism Sudden death Post MI syndrome Management Initial management for ACS Immediate clinical assessment , ECG, Troponin Oxygen + cardiac rhythm monitoring oral Aspirin 300 mg oral Metoprolol 50-100 mg If ST segment elevation MI Reperfusion therapy:- immediate reperfusion therapy with percutaneous coronary intervention(PCI). Thrombolytic therapy:- if primary PCI is not possible (eg- tenecteplase , reteplase) Antithrombotic therapy:- aspirin 75-325mg clopidogrel 300mg Anti-anginal therapy:- -sublingual glyceryl trinitrate(300-500µg) -β-blockers- Atenolol 5-10 mf Other- -Renin-angiotensin blockade -mineralocorticoid receptor antagonist -Lipid lowering therapy -Smoking cesstion -Diet and exercise Thank you